Merseyside & Cheshire Cancer Network Dashboard
Merseyside & Cheshire Cancer Network Dashboard Merseyside & Cheshire Cancer Network Dashboard
2. Screening a. Bowel b. Breast c. Cervical Bowel cancer screening Roll out of the national bowel cancer screening programme has been achieved within Cheshire and Merseyside. This programme invites most men and women aged 60-69 years. Self referral was an option during the first phase of roll out. The CRS (2009) second annual report highlights that 4.5 million kits have been sent out resulting in 17,000 polyp removals and 4,000 cancers being diagnosed. The extension of bowel screening to men and women aged 70-75 from 2010 is a Vital Sign in the NHS Operating Framework (VSA10). There is currently no national target for bowel screening although pilot studies resulted in around a 60% coverage rate. There is considerable variation of uptake amongst those in lower socio economic areas, within different ethnicity and cultures and in those who are no registered with a GP. Breast screening The NHS Breast Screening Programme provides free breast screening every three years for all women in the UK aged 50 and over. Around one-and-a-half million women are screened in the UK each year. Women aged between 50 and 70 are now routinely invited. The NHS Breast Screening Programme will extend the age range of women eligible for breast screening to ages 47 to 73 by 2012. The national target for breast screening coverage is 70%. Cervical screening All women between the ages of 25 and 64 are eligible for a free cervical screening test every three to five years. The NHS Cervical Screening Programme now offers screening at different intervals depending on age. This means that women are provided with a more targeted and effective screening programme. The national coverage rate is 80% The new intervals are; Age Duration 25 First invitation 25 - 49 3 yearly 50 - 64 5 yearly 65+ Only screen those who have not been screened since age 50 or have had recent abnormal tests Achieving a 14 day turnaround time for results of cervical screening is a Vital Sign in the NHS Operating Framework (VSA15). This is to be achieved by the end of 2010. Version 2 Cancer Dashboard MCCN 2010 6
Operational leadership 2a Does the PCT have a screening operational and strategic lead in place? Level 1 The PCT does not have an operational screening lead in place Level 2 The PCT designates this responsibility to a number of people Level 3 The PCT has an operational and strategic lead Level 4 The PCT has an operational and strategic lead and they represent the PCT at a variety of screening meetings Level 5 Excellent The PCT has an operational and strategic lead and they represent the PCT at a variety of screening meetings. They are actively engaged in the cancer network Self assessment rating and public health network screening groups Evidence summary: Implementation plans 2b Does the PCT have an implementation plan for screening in place? Level 1 No plan in place Level 2 Plans being developed Level 3 An operational plan is only available for some of the screening programmes Level 4 A full operational plan is in place and can be shared for all cancer screening programmes Level 5 Excellent A full operational plan is in place and can be shared for all cancer screening programmes. Action plans and performance is reviewed regularly and shared Self assessment rating with the PCT board. Evidence summary: Version 2 Cancer Dashboard MCCN 2010 7
- Page 1 and 2: Merseyside & Cheshire Cancer Networ
- Page 3 and 4: Baseline key metrics and indicators
- Page 5: Public awareness 1b Has the PCT eng
- Page 9 and 10: Breast cancer screening coverage 2f
- Page 11 and 12: 3. Delays in presentation/ Referral
- Page 13 and 14: 4. Staging The information for the
- Page 15 and 16: 4f Level 1 Level 2 Level 3 Level 4
- Page 17 and 18: 4l Level 1 Level 2 Level 3 Level 4
- Page 19 and 20: How will the PCT reduce cancer mort
- Page 21 and 22: 8. Local Plans: Findings from local
- Page 23: Cancer Performance summary table fo
2. Screening<br />
a. Bowel<br />
b. Breast<br />
c. Cervical<br />
Bowel cancer screening<br />
Roll out of the national bowel cancer screening programme has been achieved within <strong>Cheshire</strong><br />
and <strong>Merseyside</strong>. This programme invites most men and women aged 60-69 years. Self referral<br />
was an option during the first phase of roll out. The CRS (2009) second annual report highlights<br />
that 4.5 million kits have been sent out resulting in 17,000 polyp removals and 4,000 cancers<br />
being diagnosed.<br />
The extension of bowel screening to men and women aged 70-75 from 2010 is a Vital Sign in the<br />
NHS Operating Framework (VSA10).<br />
There is currently no national target for bowel screening although pilot studies resulted in around<br />
a 60% coverage rate. There is considerable variation of uptake amongst those in lower socio<br />
economic areas, within different ethnicity and cultures and in those who are no registered with a<br />
GP.<br />
Breast screening<br />
The NHS Breast Screening Programme provides free breast screening every three years for all<br />
women in the UK aged 50 and over. Around one-and-a-half million women are screened in the<br />
UK each year. Women aged between 50 and 70 are now routinely invited.<br />
The NHS Breast Screening Programme will extend the age range of women eligible for breast<br />
screening to ages 47 to 73 by 2012.<br />
The national target for breast screening coverage is 70%.<br />
Cervical screening<br />
All women between the ages of 25 and 64 are eligible for a free cervical screening test every<br />
three to five years. The NHS Cervical Screening Programme now offers screening at different<br />
intervals depending on age. This means that women are provided with a more targeted and<br />
effective screening programme. The national coverage rate is 80%<br />
The new intervals are;<br />
Age Duration<br />
25 First invitation<br />
25 - 49 3 yearly<br />
50 - 64 5 yearly<br />
65+ Only screen those who have not been screened since age 50 or have had recent<br />
abnormal tests<br />
Achieving a 14 day turnaround time for results of cervical screening is a Vital Sign in the NHS<br />
Operating Framework (VSA15). This is to be achieved by the end of 2010.<br />
Version 2 <strong>Cancer</strong> <strong>Dashboard</strong> MCCN 2010 6
Change language